Marriott, Anthony C. http://orcid.org/0000-0002-8862-9852
Gooch, Karen E.
Brown, Phillip J. http://orcid.org/0000-0001-6367-6495
Ryan, Kathryn A. http://orcid.org/0000-0001-8608-1144
Jones, Nicola J.
Merredew, Natasha
Wiblin, Nathan
Dibben, Oliver http://orcid.org/0000-0001-5645-9388
Bright, Helen
Hallis, Bassam
Whittaker, Catherine J.
Carroll, Miles W.
Funding for this research was provided by:
This work was funded by Public Health England.
Article History
Received: 7 September 2020
Accepted: 2 March 2021
First Online: 29 March 2021
Competing interests
: At the time of manuscript preparation, O.D. and H.B. were employees and shareholders of AstraZeneca plc. AstraZeneca plc are the manufacturers of Fluenz® Tetra/FluMist® Quadrivalent intranasal influenza live virus vaccine. The authors declare that there are no other competing interests.